❤️🔥 Libido & sexual function
4 mechanistic pathways · 48 options
Desire and performance are separate systems and they fail separately. Wanting to and not being able to is a vascular or hormonal problem; being able to and not wanting to is a central one — dopamine, melanocortin, prolactin or stress. Sildenafil does nothing for the second, which is why it disappoints so many people who reach for it first.
The pathways
Central desire — melanocortin & dopaminergic
Desire is generated in the brain, and the melanocortin and dopamine systems are where it lives. This pathway works on wanting rather than on blood flow, and it is the one that works in women as well as men.
Vascular & erectile function
An erection is a hemodynamic event. Nitric oxide relaxes smooth muscle, blood fills, veins compress. Erectile dysfunction is also an early warning of systemic endothelial disease — the penile arteries are narrower than the coronaries and clog first, which makes this a cardiovascular symptom worth taking seriously.
Hormonal substrate — testosterone, estrogen, prolactin, thyroid
Testosterone sets the floor under desire in both sexes. Estrogen matters for arousal and comfort in women and for libido in men, which surprises people. Prolactin and thyroid are the two most commonly missed causes, and both are a single blood test away.
Stress, sleep and the things that quietly kill desire
Libido is the first thing the body switches off when it thinks conditions are bad. Chronic stress, poor sleep, SSRIs, over-training and severe dieting all suppress it — and no amount of hormonal intervention overrides an organism that has concluded now is not the time.
Test before you choose a pathway
Every route below can be argued for on mechanism. Only bloodwork tells you which one is actually your problem — and picking the wrong pathway is the most common reason someone concludes "none of this works". Across all 4 pathways, these are the 15 markers worth having in front of you first.
Ordered together:
❤️🔥 ED & Low Libido🫀 Real Cardiovascular Risk🌡️ Adrenal & Cortisol AxisWhat actually decides this outcome, in order of size
Two systems fail separately and are bought for interchangeably. Sorting out which one is broken is worth more than everything on the 4 pathways below.
- Whether the complaint is wanting or doing, which 1 question separates. The registration trials for PDE5 inhibitors measured successful intercourse attempts in men with erectile dysfunction Goldstein 1998; the phase 3 trials for a melanocortin agonist measured desire Kingsberg 2019. Two different end points, 2 different drug classes, and 1 of them does nothing for the other.
- Whether the erectile complaint is a vascular warning arriving years early. An erection is a hemodynamic event dependent on endothelial nitric oxide, and the cavernosal arteries have a smaller caliber than the coronaries, so the same endothelial disease produces symptoms here first. Erectile dysfunction of vascular origin is often the earliest presentation of a systemic problem, which makes ApoB (Apolipoprotein B) and HbA1c (Hemoglobin A1c) part of this conversation rather than a digression from it.
- What is on the repeat prescription, where the range runs 8% to 72.7%. Sexual dysfunction occurred in 59.1% of 1,022 outpatients on antidepressants, ranging from 72.7% on citalopram to 8% on nefazodone Montejo 2001. No product below competes with a class effect of that size, and the variation between agents is the actionable part.
- Sleep, which is upstream of the hormones by 1 week. One week of sleep restricted to five hours lowered daytime testosterone in young healthy men Leproult 2011, and the largest testosterone pulse of the day depends on consolidated sleep that apnea prevents.
- The 2 blood tests that are commonly the whole explanation, both on 1 draw. Prolactin and thyroid. A raised prolactin has a structured workup and a consensus behind it Petersenn 2023, and both are one draw.
The order to run these in, and what has to be true first
Split the complaint, test the two cheap hormones, treat the cardiovascular finding if there is one, then choose the pathway. The split is free, takes 1 question, and decides everything after it.
- Ask whether nocturnal and early-morning erections still happen, since 3 to 5 occur per night in an intact system. If they do, the vascular and neural machinery is intact and the problem is central, contextual or pharmacological. If they do not, the hemodynamic pathway is the right one. That single question sorts most readers into Central desire — melanocortin & dopaminergic or Vascular & erectile function without a test.
- One morning draw. Total Testosterone with Free Testosterone and SHBG (Sex Hormone-Binding Globulin), Prolactin, TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine), Estradiol, Sensitive (LC/MS-MS) in men, and HbA1c (Hemoglobin A1c) with Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) and ApoB (Apolipoprotein B) because the erectile complaint is a cardiovascular screening opportunity. Hormonal substrate — testosterone, estrogen, prolactin, thyroid is where the interpretation lives.
- Deal with the conditions before the compounds, because 3 of the top 4 causes are free to change. Stress, sleep and medication account for more of this complaint than hormones do, and Stress, sleep and the things that quietly kill desire is the pathway for all three. It is also the only one of the four where the highest-value intervention is a conversation rather than a purchase.
- Tadalafil and Sildenafil for the hemodynamic half, and they differ in a way that matters. Both inhibit PDE5 and prevent the breakdown of cyclic GMP in cavernosal smooth muscle. Sildenafil's elimination half-life is around 4 hours; tadalafil's is around 17.5, which is why it supports daily rather than on-demand use and why the two produce different experiences of the same mechanism.
- PT-141 for the desire half. Bremelanotide is a melanocortin receptor agonist with two randomized phase 3 trials showing significant increases in desire scores Kingsberg 2019, given on demand, with nausea as the dose-limiting effect.
- Cabergoline only against a raised Prolactin, and Enclomiphene only against a genuinely low testosterone with non-elevated gonadotropins. Both are targeted agents that do nothing against a normal number, and both belong to Upstream stimulation — keeping the axis running for the detail.
- Citrulline Malate, Pycnogenol, Beetroot (Nitrates), Tongkat Ali and Maca are the botanical and precursor layer. The first three are nitric oxide arguments: citrulline is a more effective arginine precursor than arginine itself because it bypasses intestinal and hepatic arginase, and dietary nitrate is reduced to nitrite by oral bacteria and then to nitric oxide in tissue, which is why antibacterial mouthwash abolishes the effect.
What gets bought for this that cannot move it
A PDE5 inhibitor bought for a desire problem is the most common disappointed purchase in this goal. The mechanism amplifies a nitric oxide signal that only exists once arousal has begun, so with no arousal there is nothing to amplify. The trials measured attempts that succeeded, not attempts that were wanted Goldstein 1998, and the distinction is in the outcome measure rather than in the marketing.
There is one absolute interaction on this hub and it is worth printing. PDE5 inhibitors potentiate the hypotensive effect of nitric oxide donor drugs, and the combination with an organic nitrate produces a fall in blood pressure that is dangerous rather than inconvenient Webb 2000. Anybody taking a nitrate for angina, in any form including an intermittent spray, is in a different conversation entirely.
Treating an erectile complaint only in the bedroom misses what it is telling you. If the machinery has stopped working, the endothelium is the organ under discussion, and a prescription that restores function without addressing ApoB (Apolipoprotein B), HbA1c (Hemoglobin A1c) and blood pressure has treated the symptom of a systemic disease. Endothelial function & nitric oxide is where that half belongs.
And testosterone with a normal testosterone is the category that fails structurally. Above the threshold, desire is not androgen limited, so raising a normal number adds a suppression risk to the endogenous axis without adding the thing that was wanted. If the number is genuinely low twice on a morning draw, that is a different page, and if it is not, no amount of substrate is the answer.
How you would know it was working, on a real read-out and a real timescale
The prediction that separates the two halves of this hub: a vascular intervention changes function on the first attempt and changes no hormone, and a central intervention changes desire over weeks and also changes no hormone. If a hormone moved, the hormone was the problem.
- Total Testosterone with SHBG (Sex Hormone-Binding Globulin), morning, twice if low. This is a threshold question. The useful outcome is usually to exclude the hormonal explanation so that the money goes to the mechanism that is actually failing.
- Prolactin once, drawn calmly. It is pulsatile and stress-responsive, macroprolactin inflates a proportion of raised results, and the consensus sets out the sequence before anybody images anything Petersenn 2023.
- ApoB (Apolipoprotein B) and HbA1c (Hemoglobin A1c) at baseline, because this hub is a screening opportunity. An erectile complaint in a man in his forties with a raised ApoB has produced a cardiovascular finding that would otherwise have waited another decade, and that is the highest-value result this page can generate.
- TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine) once. Both directions of thyroid dysfunction reduce desire, both are treatable, and thyroid status also moves SHBG, which changes the free androgen fraction from a second direction.
- Desire days counted daily for four weeks, and erection quality rated per attempt. The two end points are recorded separately because the whole hub is built on the claim that they are separate things, and a single global rating collapses exactly the distinction that decides which pathway to use.
What will fool you. Placebo response in this field is large and an on-demand injectable or tablet carries a strong anticipation effect. Alcohol acutely disinhibits and chronically suppresses, so a good evening out is not evidence about a compound. And a new relationship improves every end point on this page by more than any product does, which is why the counted four weeks beats a remembered impression.
Sources read for these sections
- Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.. N Engl J Med 1998 · PMID 9580646
- Webb DJ, Muirhead GJ, Wulff M, Sutton JA, Levi R, Dinsmore WW. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina.. J Am Coll Cardiol 2000 · PMID 10898408
- Kingsberg SA. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstetrics and Gynecology 2019;134(5):899-908 · PMID 31599840
- Montejo AL. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Journal of Clinical Psychiatry 2001;62 Suppl 3:10-21 · PMID 11229449
- Leproult R. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA 2011;305(21):2173-74 · PMID 21632481
- Petersenn S, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nature Reviews Endocrinology 2023 · PMID 37670148
You have the pathways. Here is the stack.
The Libido & Sexual Function Blueprint names the one compound I would start with in each of these 4 pathways, what it was chosen over, and why — plus 20 options to swap in or stack on top, every one of them priced and linked.
Open The Libido & Sexual Function Blueprint →You know the goal. Skool has the plan.
Every pathway above is one arm of The Libido & sexual function Blueprint. The members' version has the sequence they run in, what stacks with what, and the markers that tell you to keep going or stop — alongside the Bloodwork Protocols.
Open The Libido & sexual function Blueprint in Skool →$10/mo, cancel anytime.
← Open Libido & sexual function in the interactive Vault · All 21 goals
Frequently asked questions
This goal is broken into 4 distinct mechanistic pathways — Central desire — melanocortin & dopaminergic; Vascular & erectile function; Hormonal substrate — testosterone, estrogen, prolactin, thyroid; Stress, sleep and the things that quietly kill desire — across 48 compounds and supplements. Each pathway is a different argument about how the body gets there, so the useful question is which one matches where you are actually stuck.
The one that matches your actual limitation, which bloodwork usually settles faster than guessing. An appetite drug does nothing for someone who already undereats, and a thyroid intervention does nothing if your thyroid is fine. Each pathway page lists the markers that tell you whether it is your problem.
No. The 4 pathways are listed in mechanistic order, not by strength of evidence, and neither are the 48 options inside them. A lot of what works in this space has never had the trial run, and sorting by trial count would bury exactly the compounds you came looking for.
Where this goes next
Everything above is the free case for Libido & sexual function. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.